SpineGuard SA (ALSGD.PA) Stock Price

€0.095 0%

Sign up
to add to portfolio

AI Score

Hold

  • Alternative

    6

  • Fundamental

    1

  • Technical

    3

Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.

Sign up to get access to more historical data and insights on SpineGuard SA, AI stock picks, stock alerts and much more.

Sign up

ALSGD.PA AI Stock Analysis

AI stock analysis for ALSGD.PA is missing at the moment.

Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like SpineGuard SA (ALSGD.PA) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.

Sign up and become a member to get access to AI stock analysis.

Sign up

SpineGuard SA (ALSGD.PA) Price Prediction

Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of SpineGuard SA (ALSGD.PA), currently trading at €0.095, will... Sign up to access price prediction.

Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.

About ALSGD.PA

LSE

  • SpineGuard SA provides designs, develops, and markets medical devices used in surgical procedures worldwide.

  • Symbol

    ALSGD.PA

  • Market

    EURONEXT

  • Industry

    Medical - Devices

  • Market Cap

    6M

Similar Stocks

EAPI.PA Euroapi S.A.
EAPI.PA		 €3.3
3.1%
6
ALNOV.PA Novacyt S.A.
ALNOV.PA		 €0.473
1.5%
4
ALEMG.PA Euromedis Groupe
ALEMG.PA		 €4.23
0.5%
6
ALMDT.PA Median Technologies SA
ALMDT.PA		 €2.58
9.8%
5
ALDMS.PA Diagnostic Medical Systems S.A.
ALDMS.PA		 €1.43
1%
6

News

No news articles.

ALSGD.PA Alternative Data

Web Traffic

SpineGuard SA receives an estimated 1850 monthly visitors to spineguard.com.

  • Web Traffic

    1850

  • Change from Previous Month

    652%

  • 3 Month Change

    625.5%

  • YoY Change

    625.5%

Twitter Followers

SpineGuard SA has 2,477 Twitter Followers on its main Twitter (also known as X) account, which is down by -0% over the last month.

  • Twitter Followers

    2477

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0.2%

  • YoY Change

    0.2%

Youtube Subscribers

SpineGuard SA has 152 subscribers on its main Youtube channel, up by 1.3% over the last month.

  • Youtube Subscribers

    152

  • Daily Change

    0%

  • 1 Month Change

    1.3%

  • 3 Month Change

    4.1%

Job Postings

SpineGuard SA currenly has an estimated 0 open job postings.

  • Job Postings

    0

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0%

  • YoY Change

    0%

LinkedIn Employees

According to LinkedIn, SpineGuard SA has 27 employees.

  • LinkedIn Employees

    27

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0%

  • YoY Change

    0%

News Mentions

SpineGuard SA was mentioned 0 times in the news yesterday.

  • News Mentions

    0

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0%

  • YoY Change

    0%

Reddit Mentions

SpineGuard SA has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.

  • Reddit Mentions

    0

  • 1 Month Change

    0%

  • 3 Month Change

    0%

ALSGD.PA Financials

ALSGD.PA Key Metrics

  • Total Revenue

    €2.2M

  • Net Income

    -€1.5M

  • Earnings per Share

    -€0.0312

  • Free cash flow

    -€1.9M

  • EBITDA

    -€1.8M

  • EBITDA Ratio

    -0.82856

  • Total Assets

    €9M

ALSGD.PA 2-year Revenue & Income
ALSGD.PA 2-year Free Cash Flow

ALSGD.PA Technicals

ALSGD.PA SMA
ALSGD.PA RSI

FAQ

What's the current price of SpineGuard SA (ALSGD.PA) Stock?
The price of an SpineGuard SA (ALSGD.PA) share is €0.095.

What's the market cap of SpineGuard SA?
The current market cap of SpineGuard SA is 6M.

Should I buy or sell ALSGD.PA?
SpineGuard SA shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, SpineGuard SA is better viewed as a hold or accumulate position while waiting for further developments.

Is SpineGuard SA a good investment?
The current analysis of SpineGuard SA's fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in SpineGuard SA's portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.

Is now a good time to buy SpineGuard SA (ALSGD.PA) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for SpineGuard SA stock is currently neutral, suggesting a cautious approach might be wise.

What are some stocks similar to SpineGuard SA (ALSGD.PA) that investors often compare it to?
SpineGuard SA (ALSGD.PA) is often compared to similar stocks such as Euroapi S.A., Novacyt S.A., Euromedis Groupe, Median Technologies SA and Diagnostic Medical Systems S.A..

What is the forecast for SpineGuard SA's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast SpineGuard SA's stock price to be around €0.093 in 2026. Starting from the current price of €0.095, this represents a 2.1% change in price, indicating a neutral outlook for the stock.

How to buy SpineGuard SA (ALSGD.PA) Stock?
SpineGuard SA stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy SpineGuard SA shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.